Modus Therapeutics (private company)

See something wrong or missing? Let us know
Offices:
Stockholm
Business model:
B2B
Investors:
we tracked 5 investors
You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Total investments received (USD) - we tracked 2 transactions

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Modus Therapeutics is a Swedish drug development company developing sevuparin – a novel drug to treat people suffering from Sickle Cell Disease – a painful, inherited blood disorder affecting millions of people around the globe.

Companies with similar profile to Modus Therapeutics:

CompanyCriteria
Sweden Asarina Pharma
55%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Rosetta Capital
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Sweden BoneSupport
45%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: HealthCap
  • Total raised in a similar range: 10M+ USD
Sweden OxThera
44%
  • Similar business models: B2B
  • At least one vc investor: HealthCap
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Denmark NMD Pharma
43%
  • Similar verticals: Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Sweden AMRA
43%
  • Similar verticals: Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Sweden ITBMed
43%
  • Similar verticals: Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Finland Synoste Oy
43%
  • Similar verticals: Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Finland BC Platforms
43%
  • Similar verticals: Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Finland Blueprint Genetics
43%
  • Similar verticals: Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Finland Valkee
43%
  • Similar verticals: Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Sweden Irras
43%
  • Similar verticals: Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Denmark Acarix
43%
  • Similar verticals: Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Finland Forendo Pharma
43%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one other investor: Karolinska Development
  • Total raised in a similar range: 10M+ USD
Norway Oncoinvent
43%
  • Similar verticals: Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Finland Glucostratus (Mendor)
43%
  • Similar verticals: Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Sweden Scint-X
35%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Praktikerinvest
Sweden Min Doktor
34%
  • Similar verticals: Health services
  • At least one vc investor: HealthCap
  • Total raised in a similar range: 10M+ USD
Sweden Doctrin
34%
  • Similar verticals: Health services
  • At least one vc investor: HealthCap
  • Total raised in a similar range: 10M+ USD
Norway Vaccibody
33%
  • Similar verticals: Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Norway Prediktor
33%
  • Similar verticals: Health services
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes